Paul Buckman - 01 Aug 2024 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Reporting relationship: Director
Issuer ticker: NMTC
Reported as of: 01 Aug 2024
Net transaction value: +$25,002
SEC form: 4
Accepted by SEC: 05 Aug 2024, 17:02:42 UTC
Prior SEC filing: 05 Jul 2024
Next SEC filing: 08 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephanie Swan, by Power of Attorney

Key filing fact

Paul Buckman filed Form 4 for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) on 05 Aug 2024.

Key facts

This page summarizes Paul Buckman's Form 4 filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2024, 17:02.

Change

Previous filing in this sequence was filed on 05 Jul 2024.
Current net transaction value: +$25,002.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NMTC transaction

Common Stock

Award

Transaction value: $22,397
Shares: +27,778
Change %: +34%
Price: $0.8063
Shares after: 109,026
Date: 01 Aug 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NMTC transaction Derivative

Warrants (Right to Buy)

Award

Transaction value: $2,604
Shares: +20,834
Change %
Price: $0.1250
Shares after: 20,834
Date: 01 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,834
Exercise price: $1.19
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Immediately exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .